1.Sun X., Liu Z., Sun S., Zhao S., Zhang X., Huang Y. The correlation between Demodex infestation and meibomian gland dysfunction at different ages. BMC Ophthalmol. 2022;22:388.
2.Jansen T., Kastner U., Kreuter A., Altmeyer P. Rosacea-like demodicidosis associated with acquired immunodeficiency syndrome. Br. J. Dermatol. 2001;144:139–142.
3.Chang Y.S., Huang Y.C. Role of Demodex mite infestation in rosacea: A systematic review and meta-analysis. J. Am. Acad. Dermatol. 2017;77:441–447.e6.
4.Akçınar U.G., Ünal E., Al F.D. Demodex spp. as a possible aetiopathogenic factor of acne and relation with acne severity and type. Postepy Dermatol. Alergol. 2018;35:174–181. Aycan O.M., Otlu G.H., Karaman U., Daldal N., Atambay M. Frequency of the appearance of Demodex sp. In various patient and age groups. Turkiye Parazitol. Derg. 2007;31:115–118.
5.Inci M., Kaya O.A., Inci M., Yula E., Gökçe H., Rifaioğlu M.M., Demirtas O., Yengil E. Investigating Demodex folliculorum in patients with urological cancer. Turkiye Parazitol. Derg. 2012;36:208–210.
6.Biernat M.M., Rusiecka-Ziółkowska J., Piątkowska E., Helemejko I., Biernat P., Gościniak G. Occurrence of Demodex species in patients with blepharitis and in healthy individuals: A 10-year observational study. Jpn. J. Ophthalmol. 2018;62:628–633.
7.79.Tsutsumi Y. Deposition of IgD, alpha-1-antitrypsin and alpha-1-antichymotrypsin on Demodex folliculorum and D. brevis infesting the pilosebaceous unit. Pathol. Int. 2004;54:32–34.
8.Lacey N., Russell-Hallinan A., Zouboulis C.C., Powell F.C. Demodex mites modulate sebocyte immune reaction: Possible role in the pathogenesis of rosacea. Br. J. Dermatol. 2018;179:420–430.
9.Jarmuda S., O’Reilly N., Żaba R., Jakubowicz O., Szkaradkiewicz A., Kavanagh K. Potential role of Demodex mites and bacteria in the induction of rosacea. J. Med. Microbiol. 2012;61:1504–1510.
10.Edslev S.M., Andersen P.S., Agner T., Saunte D.M.L., Ingham A.C., Johannesen T.B., Clausen M.-L. Identification of cutaneous fungi and mites in adult atopic dermatitis: Analysis by targeted 18S rRNA amplicon sequencing. BMC Microbiol. 2021;21:72.
11.Kim J.H., Chun Y.S., Kim J.C. Clinical and Immunological Responses in Ocular Demodecosis. J. Korean Med. Sci. 2011;26:1231–1237.
12.Lacey N., Raghallaigh S.N., Powell F.C. Demodex Mites–Commensals, Parasite or Mutualistic Organisms? Dermatology. 2011;222:128–130.
13.Chen W., Plewig G. Human demodicosis: Revisit and a proposed classification. Brit. J. Dermatol. 2014;170:1219–1225.
14.Rather P., Hassan I. Human Demodex Mite: The Versatile Mite of Dermatological Importance. Indian J. Dermatol. 2014;59:60–66.
15.Paichitrojjana A. Demodex: The worst enemies are the ones that used to be friends. Dermatol. Rep. 2022;14:9339.
16.Palopoli M.F., Fergus D.J., Minot S., Pei D.T., Simison W.B., Fernandez-Silva I., Thoemmes M.S., Dunn R.R., Trautwein M. Global divergence of the human follicle mite Demodex folliculorum: Persistent associations between host ancestry and mite lineages. Proc. Natl. Acad. Sci. USA. 2015;112:15958–15963.
17.Paichitrojjana A., Chalermchai T. The association between acne vulgaris, acne vulgaris with nonspecific facial dermatitis, and Demodex mite presence. Clin. Cosmet. Investig. Dermatol. 2024;17:137–146.
18.Whiting C., Abdel Azim S., Friedman A. The skin microbiome and its significance for dermatologists. Am. J. Clin. Dermatol. 2024;25:169–177.
19.Chudzicka-Strugała I., Gołębiewska I., Brudecki G., Elamin W., Zwoździak B. Demodicosis in different age groups and alternative treatment options: A review. J. Clin. Med. 2023;12:1649.
20.Hsu C.K., Hsu M.L., Lee J.Y.-Y. Demodicosis: A clinicopathological study. J. Am. Acad. Dermatol. 2009;60:453–462.
21.Dopytalska K., Lipa K., Sobolewski P., Szymańska E., Walecka I. Role of Demodex folliculorum in dermatology. Dermatol. Rev./Przegl. Dermatol. 2019;106:507–514.
22.Wesolowska M., Knysz B., Reich A., Blazejewska D., Czarnecki M., Gladysz A., Pozowski A., Misiuk-Hojlo M. Prevalence of Demodex spp. in eyelash follicles in different populations. Arch. Med. Sci. 2014;10:319–324.
23.7.Pyzia J., Mańkowska K., Czepita M., Kot K., Łanocha-Arendarczyk N., Czepita D., Kosik-Bogacka D.I. Demodex species and culturable microorganism co-infestations in patients with blepharitis. Life. 2023;13:1827.
24.Aktas Karabay E., Aksu Cerman A. Demodex folliculorum infestations in common facial dermatoses: Acne vulgaris, rosacea, seborrheic dermatitis. An. Bras. Dermatol. 2020;95:187–193.
25.Lacey N., Russell-Hallinan A., Powell F.C. Study of Demodex mites: Challenges and solutions. J. Eur. Acad. Dermatol. Venereol. 2016;30:764–775.
26.Rychlik K., Sternicka J., Zabłotna M., Nowicki R.J., Bieniaszewski L., Purzycka-Bohdan D. The prevalence of Demodex spp. infestation in dermatological patients in northern Poland. Life. 2024;14:1196.
27.Paichitrojjana A. The worst enemies are the ones that used to be friends. Dermatol. Rep. 2022;14:9339.
28.Aşkın Ü., Seçkin D. Comparison of the two techniques for measurement of the density of Demodex folliculorum: Standardized skin surface biopsy and direct microscopic examination. Br. J. Dermatol. 2010;162:1124–1126.
29.Forton F.M. Standardized skin surface biopsy: Method to estimate the Demodex folliculorum density, not to study the Demodex folliculorum prevalence. J. Eur. Acad. Dermatol. Venereol. 2007;21:1301–1302.
30.Yun C.H., Yun J.H., Baek J.O., Roh J.Y., Lee J.R. Demodex mite density determinations by standardized skin surface biopsy and direct microscopic examination and their relations with clinical types and distribution patterns. Ann. Dermatol. 2017;29:137–142.
31.Bunyaratavej S., Rujitharanawong C., Kasemsarn P., Boonchai W., Muanprasert C., Matthapan L., Leeyaphan C. Skin scrapings versus standardized skin surface biopsy to detect Demodex mites in patients with facial erythema of uncertain cause: A comparative study. Indian J. Dermatol. Venereol. Leprol. 2016;82:19–22.
32.Żychowska M., Tognetti L., Rubegni P., Cinotti E. Pigmented Demodex folliculorum: A novel dermoscopic finding in brown facial macules. Dermatol. Pract. Concept. 2024;14:e2024044.
33.Kargadouri A., Beler S., Patsoula E. Data on Demodex ectoparasite infestation in patients attending an outpatient clinic in Greece. Parasitologia. 2024;4:129–136.
34.Chang Y.-S., Huang Y.-C. Role of Demodex mite infestation in rosacea: A systematic review and meta-analysis. J. Am. Acad. Dermatol. 2017;77:441–447.e6.
35.Barnett M.O., Simmons B.O., Vollmer P.O., Patel A., Whitson W.E., Berdy G.J., Karpecki P.O., Periman L.M., Holdbrook M.B., Baba S.N.O., et al. The impact of Demodex blepharitis on patient symptoms and daily life. Optom. Vis. Sci. 2024;101:151–156.
36.van Zuuren E.J., Arents B.W.M., van der Linden M.M.D., Vermeulen S., Fedorowicz Z., Tan J. Rosacea: New concepts in classification and treatment. Am. J. Clin. Dermatol. 2021;22:457–465.
37.Forton F.M., De Maertelae V. Papulopustular rosacea and rosacea-like demodicosis: Two phenotypes of the same disease? J. Eur. Acad. Dermatol. Venereol. 2018;32:1011–1016.
38.Gonzalez-Hinojosa D., Jaime-Villalonga A., Aguilar-Montes G., Lammoglia-Ordiales L. Demodex and rosacea: Is there a relationship? Indian. J. Ophthalmol. 2018;66:36–38.
39.Elston C.A., Elston D.M. Demodex mites. Clin. Dermatol. 2014;32:739–743.
40.Forton F.M. Rosacea, an infectious disease: Why rosacea with papulopustules should be considered a demodicosis. A narrative review. J. Eur. Acad. Dermatol. Venereol. 2022;36:987–1002.
41.Lacey N., Russell-Hallinan A., Zouboulis C.C., Powell F.C. Demodex mites modulate sebocyte immune reaction: Possible role in the pathogenesis of rosacea. Br. J. Dermatol. 2018;179:420–430.
42.Forton F., De Maertelaer V. Erythematotelangiectatic rosacea may be associated with a subclinical stage of demodicosis: A case–control study. J. Dermatol. 2019;181:818–825.
43.Trave I., Salvi I., Schiavetti I., Canepa P., Silva C., Parodi A., Cozzani E. Presence of Demodex spp. on the face and scalp in patients affected by papulopustular rosacea of the face. Ital. J. Dermatol. Venereol. 2024;159:425–429.
44.Zeytun E., Yazici M. Human Demodex mites (Acari: Demodicidae) as a possible etiological factor in rosacea: A cross-sectional study from Turkey. Syst. Appl. Acarol. 2024;29:527–538.
45.Trave I., Salvi I., Canepa P., Parodi A., Cozzani E. Detection of Demodex mites in papulopustular rosacea using microscopic examination and polymerase chain reaction: A comparative case-control study. Arch. Dermatol. Res. 2024;316:485.
46.Kiratli Nalbant E., Balta I., Eksioglu M. Evaluation of the relationship between Demodex infestation and obesity in rosacea patients. J. Cosmet. Dermatol. 2024;23:3382–3387.
47.Ferhatosmanoğlu A., Baykal Selçuk L., Aksu Arıca D., Kapan O. The relationship of Demodex density with acne severity. Turk. J. Dermatol. 2023;17:52–56.
48.Zhao Y., Hu L., Wu L., Ma J. A meta-analysis of the association between acne vulgaris and Demodex infestation. Univ. Sci. B Biomed. Biotechnol. 2012;13:192–202.
49.Güvendi Akçınara U., Ünal E. Demodex spp. as a possible aetiopathogenic factor of acne and relation with acne severity and type. Adv. Dermatol. Allergol. 2018;XXXV:174–181.
50.Murphy O., O’Dwyer V., Lloyd-McKernan A. Ocular Demodex folliculorum: Prevalence and associated symptoms in an Irish population. Int. Ophthalmol. 2019;39:405–417.
51.Cheng A.M., Hwang J., Dermer H., Galor A. Prevalence of ocular demodicosis in an older population and its association with symptoms and signs of dry eye. Cornea. 2021;40:995–1001.
52.Liang H., Randon M., Michee S., Tahiri R., Labbe A., Baudouin C. In vivo confocal microscopy evaluation of ocular and cutaneous alterations in patients with rosacea. Br. J. Ophthalmol. 2017;101:268–274.
53.Rhee M.K., Yeu E., Barnett M.O., Rapuano C.J., Dhaliwal D.K., Nichols K.K.O., Karpecki P.O., Mah F.S., Chan A., Mun J., et al. Demodex blepharitis: A comprehensive review of the disease, current management, and emerging therapies. Eye Contact Lens. 2023;49:311–318.
54.Shah P., Stein R.L., Perry H. Update on the management of Demodex blepharitis. Cornea. 2022;41:934–939.
55.O’Dell L., Dierker D.S., Devries D.K., Garlich J., Whitley W.O., Holdbrook M., Yeu E. Psychosocial impact of Demodex blepharitis. Clin. Ophthalmol. 2022;16:2979–2987.
56.Akkucuk S., Kaya O.M., Aslan L., Ozdemir T., Uslu U. Prevalence of Demodex folliculorum and Demodex brevis in patients with blepharitis and chalazion. Int. Ophthalmol. 2023;43:1249–1259.
57.Sarac G., Cankaya C., Nur Ozcan K., Cenk H., Karincaoglu Kapicioglu Y. Increased frequency of Demodex blepharitis in rosacea and facial demodicosis patients. J. Cosmet. Dermatol. 2020;19:1260–1265.
58.Sahni D.R., Feldman S.R., Taylor S.L. Ivermectin 1% (CD5024) for the treatment of rosacea. Expert Opin. Pharmacother. 2018;19:511–516.
59.Ávila M.Y., Martínez-Pulgarín D.F., Rizo Madrid C. Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: A randomized clinical trial. Cont. Lens Anterior Eye. 2021;44:101326.
60.Paichitrojjana A., Paichitrojjana A. Die-off reaction of Demodex mites after treating demodicosis with oral ivermectin: A case report. JAAD Case Rep. 2024;52:1–3.
61.Trave I., Micalizzi C., Cozzani E., Gasparini G., Parodi A. Papulopustular rosacea treated with ivermectin 1% cream: Remission of the Demodex mite infestation over time and evaluation of clinical relapses. Dermatol. Pract. Concept. 2022;12:e2022201.
62.Huang H.P., Hsu C.K., Lee J.Y.Y. Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol. Dermatol. Ther. 2021;34:e14899.
63.Yeh C.H., Tsai J., Huang Y.C., Wang H.B. Topical metronidazole versus ivermectin for low-density Demodex rosacea: A rater-blinded, randomized, split-face trial. Acta Derm. Venereol. 2022;102:adv00811.
64.Valvecchia F., Greco L., Perrone F., Logioco C., Caride G.G., Perrone L., Valvecchia G., Albertazzi R., Zanutigh V. Topical ivermectin ointment treatment of Demodex blepharitis: A 6-year retrospective study. Graefe’s Arch. Clin. Exp. Ophthalmol. 2024;262:1281–1288.
65.Chen W., Plewig G. Human demodicosis: Revisit and a proposed classification. Br. J. Dermatol. 2014;170:1219–1225.
66.Jacob S., VanDaele M.A., Brown J.N. Treatment of Demodex-associated inflammatory skin conditions: A systematic review. Dermatol. Ther. 2019;32:e13103.
67.51.Veraldi S., Pisapia A., Nazzaro G., Boneschi V. Unilateral rosacea, unilateral demodicidosis, unilateral Demodex sp. folliculitis: Three names for the same disease. J. Cosmet. Dermatol. 2022;21:335–336.
68.Chioveanu F.G., Niculet E., Torlac C., Busila C., Tatu A.L. Beyond the surface: Understanding Demodex and its link to blepharitis and facial dermatoses. Clin. Ophthalmol. 2024;18:1801–1810.
69.Lam N.S.K., Long X.X., Griffin R.C., Chen M.K., Doery J.C. Can the tea tree oil (Australian native plant: Melaleuca alternifolia Cheel) be an alternative treatment for human demodicosis on skin? Parasitology. 2018;145:1510–1520.
70.Paichitrojjana A., Paichitrojjana A. Case series of demodicosis in acne vulgaris patients. Clin. Cosmet. Investig. Dermatol. 2023;16:3363–3368.
71.Gülbaşaran F., Sarımustafa S., Özbağçıvan Ö., Köse Ş., Avcı E. Investigation of factors associated with gut microbiota in Demodex-associated skin conditions. Turkiye Parazitol. Derg. 2024;48:171–177.
72.Das S, Reynolds RV. Recent advances in acne pathogenesis: implications for therapy. Am J Clin Dermatol. 2014;15:479–88.
73.Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol. 2016;74:945–73.
74.Kucharska A, Szmurło A, Siñska B. Significance of diet in treated and untreated acne vulgaris. Adv Dermatol Allergol. 2016;33:81–6.
75.4.Romañska-Gocka K, Woźniak M, Kaczmarek-Skamira E, Zegarska B. The possible role of diet in the pathogenesis of adult female acne. Adv Dermatol Allergol. 2016;33:416–42.
76.Khunger N, Kumar C. A clinico-epidemiological study of adult acne: is it different from adolescent acne? Indian. J Dermatol Venereol Leprol. 2012;78:335–41.
77.Goulden V, Clark SM, Cunliffe WJ. Post-adolescent acne: a review of clinical features. Br J Dermatol. 1997;136:66–70.
78.Capitanio B, Sinagra JL, Bordignon V, et al. Underestimated clinical features of postadolescent acne. J Am Acad Dermatol. 2010;63:782–8.
79.Balta I, Ekiz O, Ozuguz P, et al. Insulin resistance in patients with post-adolescent acne. Int J Dermatol. 2015;54:662–6.
80.Aytekin S, Goktay F, Yasar S, et al. Tips and tricks on Demodex density examination by standardized skin surface biopsy. J Eur Acad Dermatol Venereol. 2016;30:126–8.
81.Talghini S, Fouladi DF, Babaeinejad S, et al. Demodex mite, rosacea and skin melanoma; coincidence or association? Turkiye Parazitol Derg. 2015;39:41–6.
82.Forton FM, Germaux MA, Thibaut SC, et al. Demodicosis: descriptive classification and status of Rosacea, in response to prior classification proposed. J Eur Acad Dermatol Venereol. 2015;29:829–32.
83.Elston CA, Elston DM. Demodex mites. Clin Dermatol. 2014;32:739–43.
84.Rusiecka-Ziolkowska J, Nokiel M, Fleischer M. Demodex – an old pathogen or a new one? Adv Clin Exp Med. 2014;23:295–8.
85.Lacey N, Russell-Hallinan A, Powell FC. Study of Demodex mites. Challenges and solutions. J Eur Acad Dermatol Venereol. 2016;30:764–75.
86.Chen W, Plewig G. Human demodicosis: revisit and a proposed classification. Br J Dermatol. 2014;170:1219–25.
87.Eismann R, Bramsiepe I, Danz B, et al. Abscessing nodular demodicosis: therapy with ivermectin and permethrin. J Eur Acad Dermatol Venereol. 2010;24:79–81.
88.Guerrero-Gonzalez GA, Herz-Ruelas ME, Gomez-Flores M, et al. Crusted demodicosis in an immunocompetent pediatric patient. Case Rep Dermatol Med 2014; 2014:458046.
89.Chovatiya RJ, Colegio OR. Demodicosis in renal transplant recipients. Am J Transplant. 2016;16:712–16.
90.Karincaoglu Y, Esrefoglu Seyhan M, Bayram N, et al. Incidence of Demodex folliculorum in patients with end stage chronic renal failure. Ren Fail. 2005;27:495–9.
91.Yagdiran Duzgun O, Aytekin S. Comparison of Demodex folliculorum density in haemodialysis patients with a control group. J Eur Acad Dermatol Venereol. 2007;21:480–3.
92.Liang L, Safran S, Gao Y, et al. Ocular demodicosis as a potential cause of pediatric blepharoconjunctivitis. Cornea. 2010;29:1386–91.
93.Zhao YE, Guo N, Xun M, et al. Sociodemographic characteristics and risk factor analysis of Demodex infestation (Acari: Demodicidae. J Zhejiang Univ Sci B. 2011;12:998–1007.
94.Doshi A, Zaheer A, Stiller MJ. A comparison of current acne grading systems and proposal of a novel system. Int J Dermatol. 1997;36:416–8.
95.Ramli R, Malik AS, Hani AF, Jamil A. Acne analysis, grading and computational assessment methods: An overview. Skin Res Technol. 2012;18:1–14.
96.Askin U, Seckin D. Comparison of the two techniques for measurement of the density of Demodex folliculorum: standardized skin surface biopsy and direct microscopic examination. Br J Dermatol. 2010;162:1124–6.
97.Turgut Erdemir A, Gurel MS, Koku Aksu AE, et al. Demodex mites in acne rosacea: reflectance confocal microscopic study. Australas J Dermatol. 2017;58:e26–30.
98.Firat PY, Gecit I, Depecik F, et al. [Demodex spp. positivity among laboratory staff, kitchen staff, cleaning workers and nurses working in a state hospital] Turkiye Parazitol Derg. 2010;34:164–7.
99.Casas C, Paul C, Lahfa ML, et al. Quantification of Demodex folliculorum by PCR in rosacea and its relationship to skin innate immune activation. Exp Dermatol. 2012;21:906–10.
100.Dolenc-Voljc M, Pohar M, Lunder T. Density of Demodex folliculorum in perioral dermatitis. Acta Derm Venereol. 2005;85:211–5.
(còn nữa)